In this episode of the Change Life Destiny podcast, host Stephanie welcomes Amitay Eshel, co-founder of Young Goose, to explore how science and innovation are reshaping skincare and wellness. Amitay shares his fascinating journey from serving in the Israeli military to leading breakthroughs in skincare, including the use of NAD, red light therapy, and cutting-edge molecules like spermidine to enhance skin health and cellular rejuvenation.

Discover real-world case studies, the transformative impact of personalized medicine, and Amitay’s vision for the future of healthcare, including metabolomics testing. Whether you're curious about skincare science or futuristic health trends, this episode is packed with insights to inspire and inform your wellness journey.

Timestamps
00:00 Welcome to the Change Life Destiny Podcast
00:45 Meet Amitay Eshel from Young Goose
02:00 From Military Service to Skincare Science
05:12 Innovations in Anti-Aging and Cellular Health
12:35 Real Stories: Transformative Skincare Results
18:15 The Future of Personalized Skincare
24:50 Virtual Identities and Health Technology
30:00 Closing Thoughts and Thank You

Get in touch with Amitay:
Website
Instagram
LinkedIn

Tune in to learn how skincare meets science and opens doors to the future of wellness!

Change Life & Destiny is a movement to excite, engage, and educate communities about the importance of taking control of our health and wellness. We highlight the latest and greatest technologies that can restore health, prevent disease, and promote wellness, as well as practitioners who are using cutting-edge technology to help patients take control of their health.

Learn more about us here:

Website: https://www.changelifedestiny.com/

Instagram: https://www.instagram.com/changinglifedestiny/

LinkedIn: https://www.linkedin.com/company/changelifedestiny/

YouTube: https://www.youtube.com/@changelifedestiny

Facebook: https://www.facebook.com/changelifedestiny

Want to learn more? Visit our website or follow us on Instagram, Facebook Youtube, and LinkedIn.